yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853086-27BAF7EA-40C9-4552-A72E-37733FF892D8
Q27853086-27BAF7EA-40C9-4552-A72E-37733FF892D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853086-27BAF7EA-40C9-4552-A72E-37733FF892D8
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer
P2860
Q27853086-27BAF7EA-40C9-4552-A72E-37733FF892D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853086-27BAF7EA-40C9-4552-A72E-37733FF892D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0074cef0c7f342b6cb541fb37301e47f20bf7d49
P2860
Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.